Understanding Herpes Simplex Keratitis
Herpes simplex keratitis (HSK) is a viral infection of the cornea caused by herpes simplex virus type 1 (HSV-1). The cornea is the clear, dome-shaped front surface of the eye responsible for focusing light and protecting the internal structures of the eye. When HSV-1 infects the cornea, it can cause inflammation, pain, and tissue damage that may affect your vision if not properly treated.
HSV-1 is the same virus responsible for cold sores around the mouth. Many people carry this virus without knowing it, as the initial infection often occurs during childhood and may produce no noticeable symptoms. After the initial infection, the virus travels along nerve fibers and becomes dormant in nerve clusters called ganglia, most often the trigeminal ganglion near the base of the skull. The virus can remain inactive for years or decades before reactivating and traveling back along nerve pathways to affect the cornea.
Herpes simplex keratitis is one of the leading infectious causes of corneal blindness in developed countries. Recognizing its symptoms early and receiving prompt treatment are essential steps in protecting your vision.
Most people first encounter HSV-1 through direct contact with an infected person, often during childhood. After this primary infection resolves, the virus becomes latent in the trigeminal ganglion, the nerve cluster that supplies sensation to the face, including the cornea.
When the virus reactivates, it can travel along any branch of the trigeminal nerve. If it follows the ophthalmic branch, the virus reaches the surface of the eye and can infect corneal tissue. Reactivation can be triggered by a variety of factors, including:
- Physical or emotional stress
- Illness, fever, or a weakened immune system
- Prolonged sun exposure or ultraviolet light
- Eye injury or trauma
- Hormonal changes
- Certain medications that suppress the immune system
- Eye surgery or dental procedures involving the trigeminal nerve area
Herpes simplex keratitis results from viral reactivation rather than a new infection. The virus has been present in the body since the original exposure, and corneal involvement represents a recurrence of viral activity along a specific nerve pathway.
Who Should Seek Evaluation for Herpes Simplex Keratitis
If you experience any combination of eye pain, redness, tearing, sensitivity to light, or blurred vision, you should seek evaluation from an eye care specialist. These symptoms can develop suddenly and may affect one eye, as herpes simplex keratitis typically involves a single eye during any given episode. The pain may range from a mild foreign body sensation to significant discomfort, and light sensitivity can be pronounced enough to make normal indoor lighting uncomfortable.
Tearing and watery discharge are common, and your vision may appear hazy or cloudy depending on which layer of the cornea is affected. These symptoms warrant prompt evaluation because early diagnosis and treatment can significantly reduce the risk of corneal damage.
If you have a known history of oral herpes and develop any unusual eye symptoms, you should consider evaluation for possible herpes simplex keratitis. While not every cold sore episode leads to eye involvement, the presence of HSV-1 in the trigeminal ganglion means the virus has the potential to reach the cornea during reactivation.
Patients who have experienced a previous episode of HSK should be particularly vigilant. Recurrent episodes are common, and each recurrence carries the potential for additional corneal damage. If you notice the return of familiar symptoms such as eye redness, pain, or blurred vision, seeking timely care can help manage the episode before significant tissue damage occurs.
Individuals whose immune systems are suppressed due to medical conditions, organ transplantation, chemotherapy, or long-term use of corticosteroid medications may experience more frequent or more severe episodes. For these patients, establishing a relationship with a cornea specialist and having a plan in place for managing potential flare-ups is especially important. Prompt recognition and treatment of recurrences can help preserve corneal clarity and protect vision over time.
How Herpes Simplex Keratitis Develops and Progresses
When HSV-1 reactivates from its dormant state in the trigeminal ganglion, viral particles travel along nerve fibers toward the corneal surface. The virus begins replicating in corneal cells upon arrival, and the body's immune response to this viral activity produces the inflammation, pain, and tissue damage associated with herpes simplex keratitis.
The pattern of corneal involvement depends on which layer of the cornea the virus affects and how the immune system responds. In some cases, the virus directly damages corneal cells through its replication cycle. In other cases, the immune response itself contributes significantly to inflammation and scarring, which helps explain why treatment strategies differ depending on the form of HSK.
The most common initial presentation of herpes simplex keratitis involves the epithelium, the outermost layer of the cornea. In epithelial disease, the virus actively replicates within surface cells, causing them to break down and form characteristic ulcer patterns. The most recognizable of these is the dendritic ulcer, named for its branching, tree-like appearance when viewed under specialized examination.
Dendritic ulcers consist of branching lines with terminal bulbs at the ends, creating a pattern highly specific to herpes simplex infection. When fluorescein dye is applied during examination, these ulcers stain in a characteristic way visible under blue light, serving as one of the primary diagnostic tools for confirming epithelial HSK. If left untreated, dendritic ulcers can enlarge into geographic ulcers, which are larger, irregularly shaped areas of epithelial loss.
Stromal keratitis involves the deeper structural layer of the cornea, the stroma, which makes up the majority of corneal thickness. This form is particularly concerning because the stroma is responsible for corneal clarity and structural integrity. Stromal disease can result from direct viral invasion, but more commonly it is driven by the immune system's inflammatory response to viral proteins within the stromal tissue.
In stromal keratitis, the cornea becomes cloudy as inflammatory cells infiltrate the tissue. Blood vessels that do not normally extend into the clear cornea may begin growing into the affected area, a process called neovascularization. Repeated episodes of stromal inflammation can lead to progressive scarring, thinning, and lasting loss of corneal clarity.
The corneal endothelium is the innermost single-cell layer responsible for maintaining corneal clarity by pumping fluid out of the corneal tissue. Herpes simplex endotheliitis occurs when the virus or the immune response affects these endothelial cells. When endothelial cells are damaged, the cornea swells with excess fluid, causing significant blurring of vision.
Because the human corneal endothelium has limited regenerative capacity, repeated episodes of endotheliitis can lead to irreversible endothelial cell loss and chronic corneal swelling.
Forms and Variations of Herpes Simplex Keratitis
Epithelial keratitis is the most frequently encountered form and represents active viral replication on the corneal surface. The hallmark feature is the dendritic ulcer, but the spectrum also includes punctate epithelial erosions in the earliest stages and geographic ulcers in more advanced cases. Treatment focuses on stopping viral replication with antiviral medications, and most episodes respond well to appropriate therapy.
The goals in managing epithelial keratitis include eliminating active viral replication, promoting healing of the corneal surface, and preventing progression to deeper corneal involvement.
Stromal keratitis can be divided into two subtypes. Immune stromal keratitis is driven primarily by the immune response and involves inflammation of the corneal stroma without active surface ulceration. Necrotizing stromal keratitis involves active viral replication within the stroma along with intense inflammation, carrying a higher risk of severe corneal damage.
Management of stromal keratitis requires addressing both the viral component and the destructive immune response. Corticosteroid medications may be needed to control inflammation, but they must be used carefully because suppressing the immune response can allow the virus to replicate more freely. This balance is best managed by a specialist with expertise in corneal disease.
Disciform keratitis is a specific pattern of corneal inflammation affecting the endothelium and posterior stroma. It presents as a disc-shaped area of corneal swelling, often with inflammatory deposits on the inner corneal surface. This form is thought to represent an immune reaction to viral antigens near the endothelium rather than active viral replication.
Endotheliitis may present in linear, sectoral, or diffuse patterns. Each reflects a different distribution of endothelial cell damage with different implications for long-term endothelial function. Prompt treatment with appropriate anti-inflammatory and antiviral therapy is important for preserving endothelial cell density.
A significant complication that can develop after repeated episodes is neurotrophic keratopathy. The virus can damage corneal nerves during its travel along nerve fibers, reducing corneal sensation over time. When the cornea loses its normal nerve supply, the epithelium becomes more vulnerable to breakdown, healing is impaired, and the protective blink reflex may be diminished.
Patients with neurotrophic keratopathy may not feel the typical pain signals that would prompt them to seek care, allowing corneal damage to progress before it is recognized. Regular monitoring is important for patients with reduced corneal sensation.
Diagnostic Tools and Evaluation Methods
The primary diagnostic tool for herpes simplex keratitis is a thorough slit lamp examination combined with fluorescein staining. The slit lamp is a specialized microscope that allows your eye care provider to examine the cornea at high magnification, revealing the characteristic patterns that distinguish HSK from other causes of eye redness and pain.
Fluorescein dye is a safe, water-soluble stain applied to the eye surface. The dye pools in areas where the corneal epithelium is damaged, and these areas glow bright green under cobalt blue light. The branching pattern of a dendritic ulcer becomes clearly visible with fluorescein staining, providing a highly specific diagnostic finding. Rose bengal and lissamine green are additional staining agents that may highlight devitalized cells at the margins of herpetic ulcers.
Assessing corneal sensitivity provides valuable diagnostic and prognostic information. Corneal sensation is typically tested by gently touching the corneal surface with a fine wisp of cotton or using a specialized instrument called an esthesiometer. Reduced sensation in the affected eye compared to the unaffected eye supports the diagnosis of herpetic disease and indicates corneal nerve involvement.
Tracking corneal sensitivity over time helps your specialist understand the degree of nerve damage and guides decisions about ongoing management. Significantly reduced sensation raises concern for neurotrophic keratopathy.
In straightforward cases, the clinical appearance of herpes simplex keratitis is distinctive enough to establish the diagnosis without additional testing. In atypical presentations, corneal confocal microscopy allows visualization of corneal structures at the cellular level, including nerve fibers and inflammatory cells. In rare cases where diagnosis remains uncertain, polymerase chain reaction (PCR) testing of corneal samples can confirm the presence of HSV-1 DNA.
Anterior segment optical coherence tomography (OCT) provides cross-sectional images of the cornea that help evaluate the depth of stromal involvement and any structural changes from previous inflammation.
What to Expect During Evaluation and Treatment
When you visit Washington Eye Institute for evaluation, your appointment will begin with a review of your symptoms, medical history, and any previous episodes of eye or facial herpes infections. Your specialist will want to know when your symptoms started, which eye is affected, and whether you have any history of cold sores.
The examination involves a detailed slit lamp evaluation with fluorescein staining to assess the corneal surface. Your specialist will look for dendritic or geographic ulcer patterns, signs of stromal inflammation or scarring, and any evidence of endothelial involvement. Corneal sensitivity may be tested, and the pressure inside your eye will be checked.
The primary treatment for epithelial herpes simplex keratitis is antiviral medication aimed at stopping viral replication. Topical antiviral eye drops or ointments are applied directly to the affected eye according to a specific dosing schedule. Ganciclovir ophthalmic gel is a commonly used topical antiviral applied multiple times daily during the acute phase, with the frequency gradually reduced as the ulcer heals.
Oral antiviral medications such as acyclovir or valacyclovir may be prescribed as an alternative or in addition to topical therapy. Oral antivirals can be particularly useful for patients who have difficulty administering eye drops or those with more extensive disease.
When herpes simplex keratitis involves the stroma, corticosteroid eye drops may be prescribed alongside antiviral medication to reduce the immune-mediated inflammation that damages the corneal stroma. The use of corticosteroids in herpetic eye disease requires careful specialist oversight because these medications can worsen epithelial disease if active viral replication is present.
Your specialist will typically ensure that any active epithelial disease has been treated before introducing corticosteroids, and antiviral coverage is maintained throughout steroid treatment. The steroid dosage is carefully tapered over weeks to months, as abrupt discontinuation can lead to a rebound of inflammation.
After initiating treatment, regular follow-up appointments are essential to monitor healing, assess treatment response, and watch for complications. During the acute phase, visits may be scheduled every few days. As healing progresses, the interval between visits gradually lengthens. Once the active episode has resolved, your specialist will discuss strategies for reducing the risk of future recurrences and establish a long-term monitoring plan.
Your Path Through Diagnosis, Treatment, and Recovery
For many patients, the first episode of herpes simplex keratitis comes as an unexpected development. You may have carried HSV-1 for years without any eye-related symptoms. The onset of pain, redness, light sensitivity, and tearing, particularly when these symptoms affect only one eye, should prompt you to seek professional evaluation rather than relying on over-the-counter remedies.
Early diagnosis during the first episode is valuable because it establishes the diagnosis, allows prompt treatment to minimize corneal damage, and helps you and your specialist develop a plan for monitoring and managing potential future recurrences.
During active treatment, you will be using antiviral medications as directed and attending regular follow-up visits. Consistent adherence to your medication schedule is important, as missing doses can allow the virus to continue replicating and prolong the course of disease. Most episodes of epithelial keratitis show improvement within one to two weeks of appropriate antiviral therapy, though complete healing may take longer depending on the extent of the initial ulcer.
During treatment, you may need to temporarily discontinue contact lens wear. You should also take care to avoid touching or rubbing the affected eye, practice good hand hygiene, and avoid sharing towels or personal items that come into contact with your face.
After an episode resolves, an important conversation with your specialist will focus on strategies for preventing or reducing future recurrences. Research has demonstrated that long-term oral antiviral prophylaxis can significantly reduce the rate of recurrent episodes. A daily dose of oral acyclovir or valacyclovir, taken on an ongoing basis, has been shown to decrease the frequency of both epithelial and stromal recurrences.
The decision to begin prophylactic antiviral therapy depends on several factors, including the number and severity of previous episodes, the degree of corneal damage from prior recurrences, and your individual risk factors.
Managing herpes simplex keratitis is an ongoing process rather than a single treatment event. Understanding your condition empowers you to recognize early warning signs of recurrence, seek prompt treatment when needed, and take proactive steps to support your corneal health. Many patients with HSK maintain excellent vision throughout their lives with appropriate management and regular specialist care.
Lifestyle modifications that may help reduce recurrence frequency include managing stress through healthy coping strategies, protecting your eyes from excessive ultraviolet light with quality sunglasses, maintaining overall health and immune function, and getting adequate sleep and nutrition.
Preparing for Your Appointment
Arriving at your appointment well-prepared helps your specialist make the most accurate assessment. Before your visit, take note of the following information:
- When your current symptoms began and how they have progressed
- Which eye is affected and whether you have noticed symptoms in both eyes
- Any history of cold sores, fever blisters, or previous eye infections
- A complete list of your current medications, including any eye drops you are using
- Any recent illnesses, stressful events, or changes in health that preceded your symptoms
- Whether you wear contact lenses and the type and wearing schedule
- Any previous eye surgeries or procedures
In addition to the information outlined above, there are several practical items to bring to your visit:
- Your current eyeglasses and any contact lens packaging or prescriptions
- A list of all medications, supplements, and eye drops you currently use
- Your identification and any relevant referral documentation
- Sunglasses to wear after your examination, as your eyes may be sensitive to light following dilation
- A companion to drive you home if your eyes will be dilated during the visit
Your appointment is an opportunity to gain a thorough understanding of your condition. Consider asking questions such as:
- Which form of herpes simplex keratitis do I have, and how does that affect my treatment plan
- How long will I need to use antiviral medications for this episode
- What are the signs that I should watch for that would indicate a recurrence
- Would prophylactic antiviral therapy be beneficial in my case
- How might this condition affect my vision in the long term
- When can I safely return to wearing contact lenses
If you have been diagnosed with herpes simplex keratitis, preparing for long-term management is an important step. This may include setting up a schedule for regular corneal evaluations, establishing a plan for what to do if symptoms recur between scheduled visits, and discussing the potential role of prophylactic antiviral therapy. A clear understanding of your management plan can help you feel confident in navigating this condition over time.
Frequently Asked Questions About Herpes Simplex Keratitis
Herpes simplex keratitis itself is not typically spread through casual contact. However, the herpes simplex virus that causes HSK can be transmitted to others through direct contact with active viral shedding. During an active episode, it is wise to practice careful hand hygiene, avoid touching your eyes and then touching other people, and refrain from sharing towels, pillowcases, or personal items that come into contact with your face.
While herpes simplex keratitis most commonly affects one eye at a time, bilateral involvement can occur, though it is uncommon in people with healthy immune systems. Patients with weakened immune systems may be at higher risk for bilateral disease. Even in patients who typically experience unilateral episodes, the opposite eye can potentially be affected during a different reactivation event. Your specialist will examine both eyes during your evaluation.
The recurrence rate varies considerably from person to person. Some patients experience a single episode with no recurrence, while others may have multiple episodes over their lifetime. Each recurrence carries the potential for additional corneal damage. Prophylactic antiviral therapy has been shown to reduce the recurrence rate substantially and is an important tool for patients who have experienced multiple episodes or who have corneal scarring from previous recurrences.
If repeated episodes lead to significant corneal scarring that impairs vision, corneal transplantation may be considered. Washington Eye Institute's fellowship-trained cornea specialists have expertise in corneal transplant procedures, including both full-thickness and partial-thickness techniques. The decision to pursue transplantation depends on the location and density of scarring, the stability of the herpetic disease, and overall eye health. Prophylactic antiviral therapy is particularly important after transplantation, as viral reactivation can affect the transplanted tissue.
Many patients with a history of HSK can return to contact lens wear after their active disease has fully resolved, with guidance from their specialist. Contact lens use should be discontinued during any active episode and should not be resumed until the cornea has healed and your specialist confirms it is safe. Your specialist may recommend specific types of contact lenses, modified wearing schedules, or additional precautions.
Herpes simplex keratitis requires precise diagnosis, carefully tailored treatment, and ongoing management that accounts for the complex interplay between viral activity and the immune response. At Washington Eye Institute, our fellowship-trained cornea specialists bring focused expertise in diagnosing and managing all forms of herpetic corneal disease. This includes the careful use of antiviral and anti-inflammatory medications, monitoring for complications such as corneal scarring and neurotrophic keratopathy, managing recurrence prevention strategies, and performing corneal transplantation when necessary. The balance between controlling inflammation and preventing viral replication benefits from the depth of experience that fellowship training in corneal disease provides.